1023PUse of bevacizumab (Bev) in real life for first-line...

Annals of Oncology 2019 / 10 Vol. 30; Iss. Supplement

1023PUse of bevacizumab (Bev) in real life for first-line (fl) treatment of ovarian cancer (OC)/ The GINECO ENCOURAGE cohort of 500 French patients

Berton-Rigaud, D, Floquet, A, Mollon-Grange, D, Dechartres, A, Lescaut, W, Kaminsky-Forrett, M-C, Tredan, O, Largillier, R, Savoye, A M, Alexandre, J, Delbaldo, C, Malaurie, E, Barletta, H, Bosacki, C
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz250.031
Date:
October, 2019
File:
PDF, 78 KB
2019
Conversion to is in progress
Conversion to is failed